These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34980201)
1. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway. Mei J; Lin W; Li S; Tang Y; Ye Z; Lu L; Wen Y; Kan A; Zou J; Yu C; Wei W; Guo R J Exp Clin Cancer Res; 2022 Jan; 41(1):5. PubMed ID: 34980201 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis. Li P; Li Y; Ma L Pharmacol Res Perspect; 2021 Aug; 9(4):e00815. PubMed ID: 34223709 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis. Zhao H; Xie Z; Tang G; Wei S; Chen G J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189 [TBL] [Abstract][Full Text] [Related]
4. Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p. Dong S; Fu Y; Yang K; Zhang X; Miao R; Long Y; Liu C Anticancer Agents Med Chem; 2021; 21(2):278-286. PubMed ID: 32698745 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP). Tang C; Feng W; Bao Y; Du H Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016 [TBL] [Abstract][Full Text] [Related]
6. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis. Liu Z; Ouyang G; Lu W; Zhang H Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021 [TBL] [Abstract][Full Text] [Related]
8. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Guo X; Wang Y Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway. Wang J; Zhu Y; Ai X; Wan H; Jia W; Chu J; Xu B; Kong X; Kong L J Gene Med; 2023 Jun; 25(6):e3485. PubMed ID: 36811210 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
11. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related]
12. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678 [TBL] [Abstract][Full Text] [Related]
13. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway. Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483 [TBL] [Abstract][Full Text] [Related]
14. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling. Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis. Zou Y; Sun Z; Sun S J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
17. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. Liu Y; Liu J; Cui J; Zhong R; Sun G Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464 [TBL] [Abstract][Full Text] [Related]
18. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
19. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis. Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]